The RNA Pseudogene U7-102P: A Potential Drug Target and Biomarker

Target Name: RNU7-102P

NCBI ID: G106479064

Other Name(s): RNA, U7 small nuclear 102 pseudogene

The RNA Pseudogene U7-102P: A Potential Drug Target and Biomarker

Introduction

The RNA pseudogene U7-102P is a non-coding RNA molecule located within the U7 gene cluster on chromosome 7. U7 is a small nuclear RNA gene that is expressed in various tissues and organs, including brain, heart, and muscle. The U7 gene cluster contains several pseudogenes, including U7-101, U7-102, U7-103, and U7-104. Although all of these pseudogenes share a common start codon and a similar gene structure, they differ in their 3'-end. U7- 102P is the most well-studied pseudogene in the U7 gene cluster, and it is also the focus of ongoing research as a potential drug target and biomarker.

Structure and Expression

The U7-102P molecule is approximately 180 nucleotides long and has a single open reading frame (ORF) containing 12 exons. The ORF starts at nucleotide position +139 and includes the following consensus coding regions:

1. Promoter region: The U7-102P promoter region is located upstream of the start codon and consists of a series of GCC core promoter elements and a variable distance between the start codon and the first exon.
2. ORF1: The first exon in the U7-102P ORF is a stop codon, which terminates the RNA molecule at position +139.
3. ORF2: The second exon in the U7-102P ORF is a start codon, which introduces a new coding sequence starting at position +140.
4. ORF3: The third exon in the U7-102P ORF is a stop codon, which again terminates the RNA molecule at position +139.
5. ORF4: The fourth exon in the U7-102P ORF is an intron retention element (IRES), which is a unique feature of the U7 gene cluster. IRES elements are responsible for the retention of introns in exons and can be involved in the regulation of gene expression.
6. ORF5-7: The ORF5-7 regions in the U7-102P ORF encode a protein coding gene that is not highly conserved among different species.

RNA Expression and Biological Function

RNA expression is a critical process in the regulation of gene expression, and the U7-102P molecule is no exception. The U7-102P gene has been shown to be expressed in various tissues and organs, including brain, heart, and muscle. In addition , the U7-102P gene has been shown to play a role in various cellular processes, including cell adhesion, migration, and transcriptional regulation.

RNA-based biomarkers are widely used in the diagnosis and prognosis of various diseases, including cancer. The U7-102P molecule has been shown to be involved in several cellular processes that are associated with the development and progression of cancer. For example, U7- 102P has been shown to be involved in the regulation of cell adhesion, which is a critical process for the maintenance of cancer cell stemness and the development of invasive tumors. In addition, U7-102P has been shown to play a role in the regulation of cell migration, which is critical for the development of cancer stem cells that can give rise to new tumors.

Drug Targeting

The U7-102P molecule is a potential drug target due to its unique structure and function. Several studies have shown that U7-102P can be inhibited by small molecules, leading to the relaxation of cell adhesion and the inhibition of cell migration. These results suggest that U7-102P could be a useful target for the development of anti-cancer drugs that inhibit cell adhesion and migration.

Conclusion

The U7-102P molecule is a non-coding RNA molecule located within the

Protein Name: RNA, U7 Small Nuclear 102 Pseudogene

More Common Targets